National Centre for Biotechnology in Veterinary Medicine – NaCeBiVet

logo
Provider: Technology Agency of the Czech Republic
Project registration number: TN02000017
Total cost: 366 million CZK
Total support intensity: 75.23%
Major recipient: Veterinary Research Institute

 

The aim of the project is to build a long-term base of applied research, through the concentration of research capacities from seven research organizations in the field of biotechnology in veterinary medicine, animal production and related fields. In terms of impact, the project is intended to contribute to ensuring the sustainable production of quality and safe food of animal origin in the context of the implementation of the policy of reducing the consumption of antibiotics, improving the welfare of farmed animals, maintaining biodiversity in the landscape and the principles of circular economy. The results generated in the project in the form of new or innovative products or services should increase the competitiveness of the participating enterprises.

Consortium Members

25 June 2024

20240625 100818 1The National Centre for Biotechnology in Veterinary Medicine NaCeBiVet is - like the other centres - a leading force in the effort to define the future direction of research and development in their area of focus. In the case of the NaCeBiVet Centre, this is in the field of veterinary medicine and the breeding of farm and pet animals. One way to identify needs is to moderate an internal discussion between consortium members and other relevant interest groups. And this is exactly what was done on 25.06.2024, when a thematic workshop "Advanced Diagnostic Methods in Veterinary Medicine" was held in the large meeting room of the Research Institute of Veterinary Medicine, v.v.i. as part of the sub-project Management Centre and its strategic agenda.
The whole programme was divided into three panels. The legislative panel summarized information on the legal framework for the approval of veterinary technical products, including diagnostics. This was followed by a presentation of the World Organisation for Animal Health (WOAH) rules and recommendations for the diagnosis of infectious diseases in animals. The fact that, unlike human medicine, veterinary legislation is harmonised at European Union level is relevant to the whole field.
The methods of diagnosis of a relatively large number of diseases is determined centrally. The second panel focused on new developments in the field of technologies used in diagnostics, which were appropriately complemented by the experience of application personnel with the development process from the idea to the implementation of the product on the market. The third panel, which formed part of a follow-up overall discussion, presented current opportunities in diagnostics in cattle, pig and fish farming. Properly set up diagnostic procedures are a prerequisite for understanding the current situation in the individual farms and the subsequent preventive or therapeutic measures. Although diagnostics have advanced significantly over time, both technologically and in terms of interpretation, there is still room for improvement. And if the aim of the workshop was to stimulate a discussion between representatives of regulatory authorities, researchers, producers and end-users on the formulation of new ideas for strategic decision-making and for joint research and development projects targeting weaknesses, it can be concluded that this has been achieved.

20240625 133200 120240625 133157 120240625 130803 1


17 May 2024

Within the 2. Call for project proposals within the NaCeBiVet project, a total of 3 proposals were submitted, which met the formal requirements and were subsequently forwarded to the members of the Centre's Council for evaluation. A meeting of the Centre Council was held on 15 May 2024. The project proposals were presented with emphasis on the need to address the problem, the setting of the results and their subsequent application in practice. The approval of the acceptance/rejection of project applications for funding will be communicated to the Centre Council members by the end of May 2024. Subsequently, the accepted projects will be forwarded to the Technology Agency of the Czech Republic for evaluation.


15 January 2024

NCK2 1On 13 December 2023, the 2nd Ordinary Meeting of the Council of the Centre of the National Centre for Biotechnology in Veterinary Medicine Project, as the highest decision-making and controlling body, took place in the large meeting room at the headquarters of the Research Institute of Veterinary Medicine, v. v. i. The Director of the VIRVeL and also the project investigator started by presenting to the individual Council members an overview of the ongoing sub-projects in the context of their relationship to the individual directions of the Centre's research agenda, and the related change requests from the principal investigators were discussed.
In the next item on the agenda, a management and strategic sub-project aimed at coordinating the delivery of the Centre's research agenda was presented for subsequent approval. After discussion, the project was approved by all members. At the end of the meeting, the dates and parameters for the announcement of the next calls in 2024 and the schedule of the Council members' meetings were discussed.
The meeting was conducted in a hybrid format.


2 November 2023

On 1 November 2023, the Principal Investigator of the project, MVDr. Martin Faldyna, Ph.D. and the Project Manager Ing. Jan Čáslavský participated in the meeting of authorized consultants and project managers of the National Competence Centres (NCC) in Prague at the registered premises of the Technology Agency of the Czech Republic (TACR). The meeting was held with the aim of familiarizing the NCC project investigators with the requirements for the monitoring reports, the possibility of transferring the support between different years of the project, the methods of reporting publication results and, above all, a discussion on the strategic partial projects. The meeting was conducted in a pleasant atmosphere. During the session, the requirements for reporting financial indicators in the monitoring reports and other matters essential for the smooth implementation of the project were clarified.


28 June 2023

On 27 June 2023, the Project recipient received information from the Technology Agency of the Czech Republic via data mailbox regarding the "Approval notification for partial projects" that had been recommended for funding by the Centre Board. These include 17 partial projects.


13 June 2023

On Thursday, 8 June 2023, Doc. Ing. Luděk Stádník, Ph.D. from the Czech University of Life Sciences Prague, who serves as an authorized consultant for the NaCeBiVet project within the Technology Agency of the Czech Republic, visited the Veterinary Research Institute. It was an informal meeting with the Director and the project management team to discuss the details of mutual cooperation and establish communication channels.


17 May 2023

A total of 17 partial projects were submitted for evaluation under the first internal Call for Proposals. The projects underwent formal evaluation and met all the specified requirements outlined in the Call for Proposals. Subsequently, they were forwarded to the members of the Centre Board for further evaluation. The Centre Board meeting took place on 4 April 2023, with active participation from Principal Investigators of the partial projects. They presented the fundamental aspects of the topic being addressed. The Centre Board evaluated the projects and categorised them into two groups. The first group comprised projects recommended by the Board for funding, while the second group consisted of projects that were returned to the Investigators for amendments.

A specific period was allocated for amending the partial projects that had been returned. Subsequently, the amended projects were submitted to the Centre Board for consideration. Following a discussion, the Board deemed the amendments sufficient and recommended funding of the partial projects.

An overview of the approved partial projects is provided under the tab "Partial projects and results".


9 February 2023

On 31 January 2023, the first meeting of the consortium members of the National Centre for Biotechnology in Veterinary Medicine (NaCeBiVet) project, supported by the Technology Agency of the Czech Republic, took place.

The event was hosted by the recipient, the Veterinary Research Institute, on its premises in Medlanky, Brno. 


17 January 2023

On 31 January 2023, the first meeting of the NaCeBiVet project consortium will be held, including meetings with partners for the proposed partial projects. The meeting will take place on the premises of the major recipient, i.e. the Veterinary Research Institute.

Logo Eng Doplnkove Cervene

This project is co-financed with the state support from the Technology Agency of the Czech Republic under the programme of the National Competence Centres.
www.tacr.cz
Research beneficial to society.